JPWO2021132609A1 - - Google Patents

Info

Publication number
JPWO2021132609A1
JPWO2021132609A1 JP2021567697A JP2021567697A JPWO2021132609A1 JP WO2021132609 A1 JPWO2021132609 A1 JP WO2021132609A1 JP 2021567697 A JP2021567697 A JP 2021567697A JP 2021567697 A JP2021567697 A JP 2021567697A JP WO2021132609 A1 JPWO2021132609 A1 JP WO2021132609A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021567697A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021132609A1 publication Critical patent/JPWO2021132609A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2021567697A 2019-12-27 2020-12-25 Pending JPWO2021132609A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019239600 2019-12-27
PCT/JP2020/048855 WO2021132609A1 (fr) 2019-12-27 2020-12-25 Composition aqueuse

Publications (1)

Publication Number Publication Date
JPWO2021132609A1 true JPWO2021132609A1 (fr) 2021-07-01

Family

ID=76573102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021567697A Pending JPWO2021132609A1 (fr) 2019-12-27 2020-12-25

Country Status (4)

Country Link
JP (1) JPWO2021132609A1 (fr)
CN (1) CN114845734A (fr)
TW (1) TW202135822A (fr)
WO (1) WO2021132609A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물
EP4070796A4 (fr) * 2019-12-27 2024-01-17 Rohto Pharma Composition aqueuse

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0748262A (ja) * 1993-06-04 1995-02-21 Senju Pharmaceut Co Ltd 外眼部投与用組成物
JPH1160505A (ja) * 1997-05-20 1999-03-02 Senju Pharmaceut Co Ltd 防腐組成物
JPH115744A (ja) * 1997-06-16 1999-01-12 Toa Yakuhin Kk ヒアルロン酸含有の外用水溶液製剤
JP2005263792A (ja) * 2004-02-19 2005-09-29 Santen Pharmaceut Co Ltd 澄明なラタノプロスト点眼液
CA2691914C (fr) * 2007-07-11 2012-06-26 Pfizer Inc. Compositions pharmaceutiques et procedes de traitement de troubles de l'oeil sec
SG11201707117SA (en) * 2015-03-06 2017-10-30 Santen Pharmaceutical Co Ltd Ophthalmic composition

Also Published As

Publication number Publication date
TW202135822A (zh) 2021-10-01
CN114845734A (zh) 2022-08-02
WO2021132609A1 (fr) 2021-07-01

Similar Documents

Publication Publication Date Title
BR112019017762A2 (fr)
BR112021017339A2 (fr)
BR112021013854A2 (fr)
BR112021018450A2 (fr)
BR112021017939A2 (fr)
BR112021017892A2 (fr)
BR112019016141A2 (fr)
AU2020104490A4 (fr)
BR112021017738A2 (fr)
BR112021017782A2 (fr)
BR112019016138A2 (fr)
BR112019016142A2 (fr)
BR112021018168A2 (fr)
BR112021017728A2 (fr)
BR112021017234A2 (fr)
BR112021017355A2 (fr)
BR112021018102A2 (fr)
BR112021017173A2 (fr)
BR112021017083A2 (fr)
BR112021017637A2 (fr)
BR112021008711A2 (fr)
BR112021018452A2 (fr)
BR112021012348A2 (fr)
BR112021018250A2 (fr)
BR112021018084A2 (fr)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231214